Trevena, Inc.
OTC: TRVN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Carrie L. Bourdow
- Employees
- 23
- Headquarters
- Chesterbrook, United States
- IPO year
- 2014
- Market cap
- $1.3K
- Website
- https://www.trevena.com
Loading TRVN…
Loading profile data…Frequently asked questions about TRVN
What does Trevena, Inc. (TRVN) do?
Trevena, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing innovative pharmaceutical solutions for individuals suffering from central nervous system disorders. Its pipeline features several promising drug candidates: OLINVYK (Oliceridine) injection: A G protein-biased mu-opioid receptor (MOR) ligand engineered to mana...
Where does TRVN trade?
Trevena, Inc. (TRVN) trades on the Other OTC.
What sector is TRVN in?
Trevena, Inc. (TRVN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Trevena, Inc.?
Carrie L. Bourdow is the chief executive officer of Trevena, Inc. (TRVN).
Where is Trevena, Inc. headquartered?
Trevena, Inc. is headquartered in United States.
Does TRVN pay a dividend?
Trevena, Inc. (TRVN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TRVN go public?
Trevena, Inc. (TRVN) completed its initial public offering in 2014.